<tbody id="r2pcb"></tbody>
<track id="r2pcb"></track>
<option id="r2pcb"><span id="r2pcb"></span></option>

<track id="r2pcb"></track>
  • <menuitem id="r2pcb"><dfn id="r2pcb"></dfn></menuitem>
    <tbody id="r2pcb"><span id="r2pcb"></span></tbody>
    <track id="r2pcb"></track>

    [上海]博志研新2022校園招聘

    招聘詳細信息

    說明:

    此信息由博志研新審核并發布(查看原發布網址),應屆生求職網轉載該信息只是出于傳遞更多就業招聘信息,促進大學生就業的目的。如您對此轉載信息有疑義,請與原信息發布者博志研新核實,并請同時聯系本站處理該轉載信息。

    職位信息及網申地址:https://url.yingjiesheng.com/e05lpy

    公司簡介:
    上海博志研新藥物技術有限公司(簡稱"博志研新")作為一家以改良型新藥、創新藥、高端制劑為核心的藥物研發和生產服務(CRO/CDMO)企業,致力于打造國際化,前沿化的醫藥研發和創新平臺。不僅在腫瘤、心血管、免疫、神經和精神等領域具有豐富的開發經驗,在高端制劑技術(口服緩控釋、口服固體增溶、長效注射液、液體與半固體等)方向上也具有豐富的專業經驗和創新技術優勢。

    Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Having two internal R&D centers settled in Shanghai and Nanjing, and a subsidiary clinical company in Chengdu, Bocimed now established an efficient R&D team with about 200 staffs and possesses specialized R&D equipments worth more 40 million RMB. Our comprehensive R&D platform mainly focuses upon small molecule innovative drugs, modified innovative drugs, highly difficult pharmaceutical preparations, DMF&MAH and clinical research, committing to provide global pharmaceutical companies with extremely competitive drug and create international and frontier pharmaceutical R&D and innovative platform.

     

    公司擁有100多項藥物開發技術,產品聚焦在腫瘤、心血管、免疫、神經和精神等多個治療領域。公司擁有完善的內部知識產權保障制度,現有已授權的發明專利16項,在審批中的發明專利47項。

    Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. With well-established internal intellectual property system,we have 16 authorized and 47 pending approval patents up to now.

    博志研新2022校園招聘崗位:
    分析研究員
    合成研究員
    制劑研究員
    知識產權專員
    研發QA

    博志研新2022校園招聘流程:
    簡歷投遞→初試→復試→錄用

     

     

    日本100个禁止色情,高清色情是免费国产,黄色视频在线观看,色色哒,成年午夜免费影院